These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 17308086
1. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways. Niu G, Carter WB. Cancer Res; 2007 Feb 15; 67(4):1487-93. PubMed ID: 17308086 [Abstract] [Full Text] [Related]
2. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219 [Abstract] [Full Text] [Related]
3. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. Pan MH, Lin CC, Lin JK, Chen WJ. J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658 [Abstract] [Full Text] [Related]
4. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N. Cancer Res; 2005 Dec 01; 65(23):11018-25. PubMed ID: 16322251 [Abstract] [Full Text] [Related]
5. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D. Cancer Res; 2006 Feb 15; 66(4):2028-37. PubMed ID: 16489002 [Abstract] [Full Text] [Related]
6. HER2 regulatory control of angiopoietin-2 in breast cancer. Carter WB, Ward MD. Surgery; 2000 Aug 15; 128(2):153-8. PubMed ID: 10922985 [Abstract] [Full Text] [Related]
7. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation. Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F. Oncogene; 2001 Apr 19; 20(17):2101-11. PubMed ID: 11360194 [Abstract] [Full Text] [Related]
8. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Ogawa T, Nagashima Y, Wada H, Akimoto K, Chiba Y, Nagatani T, Inayama Y, Yao M, Aoki I, Ikezawa Z. Hum Pathol; 2005 Dec 19; 36(12):1273-80. PubMed ID: 16311120 [Abstract] [Full Text] [Related]
9. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma. Tokunaga E, Oki E, Kimura Y, Yamanaka T, Egashira A, Nishida K, Koga T, Morita M, Kakeji Y, Maehara Y. Breast Cancer Res Treat; 2007 Mar 19; 101(3):249-57. PubMed ID: 17006756 [Abstract] [Full Text] [Related]
10. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ. Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418 [Abstract] [Full Text] [Related]
11. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Liu ZJ, Xiao M, Balint K, Smalley KS, Brafford P, Qiu R, Pinnix CC, Li X, Herlyn M. Cancer Res; 2006 Apr 15; 66(8):4182-90. PubMed ID: 16618740 [Abstract] [Full Text] [Related]
12. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J. Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618 [Abstract] [Full Text] [Related]
13. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. Borowiec AS, Hague F, Harir N, Guénin S, Guerineau F, Gouilleux F, Roudbaraki M, Lassoued K, Ouadid-Ahidouch H. J Cell Physiol; 2007 Sep 15; 212(3):690-701. PubMed ID: 17520698 [Abstract] [Full Text] [Related]
14. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA. Cancer Res; 2007 May 01; 67(9):4199-209. PubMed ID: 17483331 [Abstract] [Full Text] [Related]
15. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Currie MJ, Gunningham SP, Han C, Scott PA, Robinson BA, Harris AL, Fox SB. Clin Cancer Res; 2001 Apr 01; 7(4):918-27. PubMed ID: 11309342 [Abstract] [Full Text] [Related]
16. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Kim KK, Lee JJ, Yang Y, You KH, Lee JH. Carcinogenesis; 2008 Apr 01; 29(4):704-12. PubMed ID: 18258606 [Abstract] [Full Text] [Related]
17. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Chang CJ, Chiu JH, Tseng LM, Chang CH, Chien TM, Wu CW, Lui WY. Eur J Clin Invest; 2006 Aug 01; 36(8):588-96. PubMed ID: 16893382 [Abstract] [Full Text] [Related]
18. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, Nose M, Komai K, Shiozawa S. Arthritis Rheum; 2007 Jul 01; 56(7):2170-9. PubMed ID: 17599743 [Abstract] [Full Text] [Related]
19. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation. Abdel-Malak NA, Mofarrahi M, Mayaki D, Khachigian LM, Hussain SN. Arterioscler Thromb Vasc Biol; 2009 Feb 01; 29(2):209-16. PubMed ID: 19112164 [Abstract] [Full Text] [Related]
20. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo. Jerome L, Alami N, Belanger S, Page V, Yu Q, Paterson J, Shiry L, Pegram M, Leyland-Jones B. Cancer Res; 2006 Jul 15; 66(14):7245-52. PubMed ID: 16849573 [Abstract] [Full Text] [Related] Page: [Next] [New Search]